Financials
Half-year Report | Jun. 18, 2024 |
Annual Report & Accounts | Feb. 22, 2024 |
Publication of FY22 Annual Report | Mar. 03, 2023 |
Preliminary Results and Notice of AGM | Jan. 24, 2023 |
Half-year Report | Jun. 28, 2022 |
Final Results | Jan. 25, 2022 |
Half-year Report | Jun. 15, 2021 |
Proxies
Result of AGM | Mar. 27, 2024 |
Result of AGM | Mar. 30, 2023 |
Results of Annual General Meeting | Mar. 30, 2022 |
Result of AGM | Mar. 24, 2021 |
Results of Annual General Meeting | Mar. 20, 2020 |
Publication of Annual Report and Notice of AGM | Jan. 23, 2020 |
Results of Annual General Meeting | Mar. 14, 2019 |
Ownership Update
Holding(s) in Company | Aug. 22, 2024 |
Holding(s) in Company | Aug. 22, 2024 |
Grant of Options | Jun. 21, 2024 |
Holding(s) in Company | May. 10, 2024 |
Holding(s) in Company | Apr. 25, 2024 |
Holding(s) in Company | Apr. 11, 2024 |
Holding(s) in Company | Apr. 10, 2024 |
Announcements
OBD pursuing EpiSwitch as companion diagnostics | Jul. 25, 2024 |
OBD's PSE test to be used in NCI trial | Jun. 06, 2024 |
OBD develops multi-cancer diagnostic test for dogs | Jun. 04, 2024 |
Notice of Results | May. 24, 2024 |
OBD partners with Goodbody Clinic on PSE test | May. 23, 2024 |
OBD partners with The London Clinic for PSE & CiRT | May. 21, 2024 |
OBD and King's College London collaborate on RA | May. 16, 2024 |